The Role of TGFB1 in the Pathophysiology of Late Stage Schizophrenia

Grant number: 1048544 | Funding period: 2013 - 2015

Completed

Abstract

Schizophrenia is triggered in people with a genetic predisposition by as yet unknown environmental factors. Having shown that changes in gene expression in the brains of people with schizophrenia vary as the disease progresses, this application seeks to understand the changes in a pathway regulated by transforming growth factor ?1 that occur late in the progression of the illness. Understanding the changes in this important pathway could affect how people with schizophrenia are treated as their disorder progresses.

Related publications (3)

SMAD4 protein is decreased in the dorsolateral prefrontal and anterior cingulate cortices in schizophrenia

AS Gibbons, D Hoyer, B Dean

2021-01-01

Objectives: Signal transduction through the mothers against decapentaplegic (SMAD) is a family of signal transduction factors that..

Understanding the pathophysiology of schizophrenia: Contributions from the Melbourne Psychiatric Brain Bank

B Dean, D Copolov, E Scarr

2016-11-01

The Melbourne Psychiatric Brain Bank came into existence 25 years ago. This review focusses on lines of research that have used ti..

The role of muscarinic receptors in the pathophysiology of mood disorders: A potential novel treatment?

WJ Jeon, B Dean, E Scarr, A Gibbons

2015-01-01

The central cholinergic system has been implicated in the pathophysiology of mood disorders. An imbalance in central cholinergic n..

University of Melbourne Researchers

Brian Dean Florey Department of Neuroscience and Mental Health